Venealternative (CAR:VNA.B) Other Current Payables : VES0.00 Mil (As of . 20)

View and export this data going back to 2023. Start your Free Trial

What is Venealternative Other Current Payables?

Venealternative's Other Current Payables for the quarter that ended in . 20 was VES0.00 Mil.

Venealternative Other Current Payables Historical Data

The historical data trend for Venealternative's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Venealternative Other Current Payables Chart

Venealternative Annual Data

Trend

Other Current Payables

Venealternative Semi-Annual Data

Other Current Payables

Venealternative Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Venealternative Other Current Payables Related Terms

Thank you for viewing the detailed overview of Venealternative's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Venealternative Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Venealternative SA (CAR:VNA.B) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Av. San Felipe, Centro, Coinasa, Floor 4, Office 43B, La Castellana, Caracas, VEN

Website

Venealternative SA is engaged in financial and business sector. Its objective is to raise resources through national and international capital markets to invest in different economic sectors and private companies in the country, with the purpose of offering real returns and becoming the savings vehicle for investors.

Venealternative Headlines

No Headlines